LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 5977
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 56199
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 26141
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 990
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8198
 
  
 
B01D SEPARATION 5129
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS444
 
  
 
A23J PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS 317
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3122

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0296,694 BIOLOGICAL GLUE AND USE THEREOF AS A MEDICAMENTOct 07, 15Oct 19, 17[A61L]
2017/0260,254 METHOD FOR PRODUCING VARIANTS HAVING AN FC WITH IMPROVED SIALYLATIONJul 31, 15Sep 14, 17[C07K]
2017/0190,753 RECOMBINANT PROTEINS HAVING FACTOR H ACTIVITYDec 19, 14Jul 06, 17[A01K, C07K]
2017/0156,313 PACKAGING FOR A MEDICAMENT USED FOR INNOVATIVE THERAPYJul 17, 15Jun 08, 17[A61J, A61K, A01N, B65D, B65B]
2017/0129,966 PRODUCTION OF FC FRAGMENTSJun 02, 15May 11, 17[C12P, A01K, C07K, B01D]
2017/0121,402 ORAL COMPOSITION OF ANTI-TNF ALPHA ANTIBODIESJun 18, 15May 04, 17[A61K, C07K]
2017/0079,928 COPOLYMERS OF FORMULA (I) AND USESMay 28, 15Mar 23, 17[A61K, C08G]
2017/0073,396 METHOD FOR PREPARING HUMAN PLASMA PROTEINSMar 10, 15Mar 16, 17[C07K]
2016/0264,637 CHIMERIC PROTEIN IN THE TREATMENT OF AMYLOIDOSISOct 31, 14Sep 15, 16[A61K, G01N, C07K]
2016/0185,847 USE OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF INFLAMMATION AND BACTERIAL INFECTIONSDec 17, 13Jun 30, 16[A61K, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9891238 Determination of the thrombogenic power of human immunoglobulinsNov 18, 11Feb 13, 18[C12Q, G01N]
9879089 Use of ADCC-optimized antibodies for treating low-responder patientsMay 01, 15Jan 30, 18[A61K, C07K]
9873745 Antibody method for treatment of a disease in which the target cells are cells which express CD20Aug 17, 15Jan 23, 18[A61K, C07K]
9850477 Method for purifying active GLA-domain coagulation proteinsNov 10, 15Dec 26, 17[C12N, C07K]
9803184 Method for immobilizing nucleic ligandsDec 30, 11Oct 31, 17[C07H, C12Q, C12N, B01J, C07K]
RE46585 Optimized FC variantsJan 12, 16Oct 24, 17[C07K]
9718856 Method for preparing a concentrate of polyvalent immunoglobulinJul 11, 12Aug 01, 17[C07K]
9718889 Monoclonal antibodies with enhanced ADCC functionFeb 09, 15Aug 01, 17[A61K, C07K]
9718890 Monoclonal antibodies with enhanced ADCC functionApr 01, 15Aug 01, 17[A61K, C07K]
9708409 Monoclonal antibodies with enhanced ADCC functionJan 16, 14Jul 18, 17[A61K, C12N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0089,422 METHOD FOR INACTIVATING A PRION PROTEINAbandonedMay 15, 14Mar 31, 16[A61K]
2016/0046,722 NOVEL MEDICAMENTS COMPRISING AN ANTIBODY COMPOSITION ENRICHED WITH PREDOMINANT CHARGE ISOFORMAbandonedMar 14, 14Feb 18, 16[C07K]
2016/0024,488 METHOD FOR PREPARING A CONCENTRATE OF FACTOR XIAbandonedOct 02, 15Jan 28, 16[C12N]
2016/0009,761 METHOD FOR PURIFYING OR DETECTING A TARGET PROTEINAbandonedSep 22, 15Jan 14, 16[C12N, C07K]
2015/0224,264 SYRINGE CONTAINING A COMPOSITION, ESPECIALLY A PHARMACEUTICAL COMPOSITION, COMPRISING IMMUNOGLOBINS, METHOD FOR THE PRODUCTION THEREOF AND USE OF SAMEAbandonedSep 12, 13Aug 13, 15[A61M]
2014/0220,147 PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII ENCAPSULATED IN MICELLESAbandonedJul 31, 12Aug 07, 14[A61K]
2014/0050,722 CHIMERIC ANTI-RICIN ANTIBODYAbandonedAug 15, 13Feb 20, 14[G01N, C07K]
2013/0259,801 SERUM AMYLOID P PROTEINAbandonedDec 16, 11Oct 03, 13[C07K]
8535668 Chimeric anti-ricin antibodyExpiredNov 04, 10Sep 17, 13[A61K, C07K]
2013/0216,522 STABILIZED HUMAN IMMUNOGLOBULIN COMPOSITIONAbandonedJun 15, 11Aug 22, 13[A61K]
2013/0189,244 RECOMBINANT OR TRANSGENIC FACTOR VII COMPOUND HAVING A MAJORITY OF GLYCAN, BIANTENNARY, BISIALYLATED AND NON-FUCOSYLATED FORMSAbandonedDec 05, 12Jul 25, 13[C12N]
2013/0090,203 DIFFERENTIAL TRANSMISSION FOR A WIND POWER INSTALLATION AND METHOD FOR OPERATION OF SAID DIFFERENTIAL TRANSMISSIONAbandonedJun 30, 11Apr 11, 13[F16H]
2012/0100,133 USE OF ANTI-CD20 ANTIBODY FOR TREATING PRIMARY INTRAOCULAR LYMPHOMAAbandonedNov 26, 09Apr 26, 12[A61K, A61P, C07K]
2012/0039,886 USE OF AN IMMUNOGLOBULIN G (IGG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES FOR TREATING NEONATAL JAUNDICE CAUSED BY MATERNAL-FOETAL INCOMPATIBILITY WITH RESPECT TO THE ABO SYSTEMAbandonedDec 16, 09Feb 16, 12[A61K, A61P]
2012/0040,905 MEANS FOR PURIFYING A COAGULATION PROTEIN, AND METHODS FOR IMPLEMENTING SAMEAbandonedFeb 19, 10Feb 16, 12[A61K, C07H, C08G, C12N, A61P, C07K]
2012/0041,056 NUCLEIC ACIDS SPECIFICALLY BINDING WITH HUMAN FACTOR VII/VIIA AND USES THEREOFAbandonedFeb 19, 10Feb 16, 12[C07H, A61K, C12Q, C12N, A61P]
2011/0318,332 IMMUNOGLOBULIN G COMPOSITIONAbandonedDec 29, 09Dec 29, 11[A61K, A61P]
2011/0319,331 NOVEL USES OF FIBRINOGENAbandonedMar 05, 10Dec 29, 11[A61K, A61P]
2011/0262,935 METHOD FOR DETECTING A PRION INFECTIONAbandonedDec 22, 09Oct 27, 11[C12Q, G01N]
2010/0323,368 Cytokine production-inducing antibodyAbandonedSep 28, 09Dec 23, 10[G01N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.